BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23566635)

  • 1. CHADS(2) and CHA(2)DS(2)VASc scores as predictors of cardioembolic sources in secondary stroke prevention.
    Sá T; Sargento-Freitas J; Pinheiro V; Martins R; Teixeira R; Silva F; Mendonça N; Cordeiro G; Gonçalves L; Providência LA; Freire-Gonçalves A; Cunha L
    Rev Port Cardiol; 2013 May; 32(5):373-8. PubMed ID: 23566635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of transesophageal echocardiography to confirm clinical utility of CHA2DS2-VASc and CHADS2 scores in atrial flutter.
    Parikh MG; Aziz Z; Krishnan K; Madias C; Trohman RG
    Am J Cardiol; 2012 Feb; 109(4):550-5. PubMed ID: 22133753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of CHADS2 and CHA2DS2-VASc scores with transesophageal echocardiography risk factors for thromboembolism in a multiethnic United States population with nonvalvular atrial fibrillation.
    Willens HJ; Gómez-Marín O; Nelson K; DeNicco A; Moscucci M
    J Am Soc Echocardiogr; 2013 Feb; 26(2):175-84. PubMed ID: 23253435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of Left Atrial Appendage Ejection Velocities with the CHADS2 and CHA2DS2-VASc Scores.
    Clark CB; Telles Garcia NA; Hackett Renner C; Ryan SM
    Echocardiography; 2016 Aug; 33(8):1195-201. PubMed ID: 27060690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-admission CHADS2, CHA2DS2-VASc, and R2CHADS2 Scores on Severity and Functional Outcome in Acute Ischemic Stroke with Atrial Fibrillation.
    Tanaka K; Yamada T; Torii T; Furuta K; Matsumoto S; Yoshimura T; Takase K; Wakata Y; Nakashima N; Kira J; Murai H
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1629-35. PubMed ID: 25906940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: Which scoring system should be used for Asians?
    Chao TF; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
    Heart Rhythm; 2016 Jan; 13(1):46-53. PubMed ID: 26277496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CHA(2)DS(2)-VASc score reflects clinical outcomes in nonvalvular atrial fibrillation patients with an initial cardioembolic stroke.
    Deguchi I; Hayashi T; Ohe Y; Kato Y; Nagoya H; Fukuoka T; Maruyama H; Horiuchi Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e343-6. PubMed ID: 23523201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
    Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation.
    Chan YH; Yiu KH; Lau KK; Yiu YF; Li SW; Lam TH; Lau CP; Siu CW; Tse HF
    Atherosclerosis; 2014 Dec; 237(2):504-13. PubMed ID: 25463082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHADS
    Wu JT; Wang SL; Chu YJ; Long DY; Dong JZ; Fan XW; Yang HT; Duan HY; Yan LJ; Qian P
    J Atheroscler Thromb; 2017 Feb; 24(2):176-184. PubMed ID: 27301462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Left Atrial Thrombi and Spontaneous Echocardiographic Contrast in the Acute Phase After Cardioembolic Stroke in Patients With Atrial Fibrillation.
    Kishima H; Mine T; Fukuhara E; Ashida K; Uchida K; Yoshimura S; Ishihara M
    J Stroke Cerebrovasc Dis; 2019 Jun; 28(6):1571-1577. PubMed ID: 30930240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Puurunen MK; Kiviniemi T; Schlitt A; Rubboli A; Dietrich B; Karjalainen P; Nyman K; Niemelä M; Lip GY; Airaksinen KE
    Thromb Res; 2014 Apr; 133(4):560-6. PubMed ID: 24461143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHADS2 and CHA2DS2-VASc scores for prediction of immediate and late stroke after coronary artery bypass graft surgery.
    Biancari F; Asim Mahar MA; Kangasniemi OP
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1304-11. PubMed ID: 23253529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of transesophageal echography in the study of embolism of cardiac origin].
    Arrigo F; Carerj S; Pizzimenti G
    Cardiologia; 1993 Dec; 38(12 Suppl 1):301-17. PubMed ID: 8020030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.
    Marcucci M; Lip GY; Nieuwlaat R; Pisters R; Crijns HJ; Iorio A
    Am J Med; 2014 Oct; 127(10):979-986.e2. PubMed ID: 24838192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible refinement of clinical thromboembolism assessment in patients with atrial fibrillation using echocardiographic parameters.
    Providência R; Botelho A; Trigo J; Quintal N; Nascimento J; Mota P; Leitão-Marques A
    Europace; 2012 Jan; 14(1):36-45. PubMed ID: 21868410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores.
    Mitchell LB; Southern DA; Galbraith D; Ghali WA; Knudtson M; Wilton SB;
    Heart; 2014 Oct; 100(19):1524-30. PubMed ID: 24860007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroke mechanism in patients with non-valvular atrial fibrillation according to the CHADS2 and CHA2 DS2 -VASc scores.
    Cha MJ; Kim YD; Nam HS; Kim J; Lee DH; Heo JH
    Eur J Neurol; 2012 Mar; 19(3):473-9. PubMed ID: 21972975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.